BusinessQuotient Limited Announces Positive Serological Disease Screening Results and Provides MosaiQ™ Development Program UpdateBy Nasdaq OMXJan 11, 2016, 12:01 PM UTC
BusinessQuotient Limited to Expand Capability of Its MosaiQ™ Next-Generation Transfusion Diagnostics Platform to Include Nucleic Acid TestingBy Nasdaq OMXJan 11, 2016, 12:00 PM UTC